Resmetrix Medical

Building a Personalized Breathing Analytics Platform


Resmetrix wishes to improve the home evolution and care of patients with cardio-respiratory insufficiency.
We develop pulmonary functions remote monitoring, easy to use, without patient intervention, to optimize the course of care and quality of life.

The Problem 
Currently we cannot continuously and quantitively measure breathing pattern and respiratory symptoms under a natural physiological condition. 
Indicators like respiratory rate Blood oxygen saturation, heart rate or spirometry pulmonary test, are unable to capture breathing pattern and its translation into symptoms.

Our Solution
Continuous Monitoring Pulmonary Functions and Breathing Patterns 

Adding those quantifiable measurement parameters provides a unique capability to accurately define breathing activity in healthy and ill people.
Accurately measuring the severity attenuation of the breathing symptoms, in different diseases, enables to adjust treatment and objectively follow the response to therapy.

Clinical Need: The growing problem of heart failure management 

 Every heart failure hospitalization increases a patient’s risk for re-hospitalization and further symptom deterioration.

Symptoms control Heart Failure

Dyspnea, the subjective experience of breathing difficulty or discomfort, is a hallmark symptom of chronic congestive heart failure (HF). 
The goal of therapy for CHF is to improve symptom management and quality of life, decrease hospitalizations, and decrease overall mortality. 
An accurate assessment of Dyspnea is especially important. 

Challenges in Managing Heart Failure
Quantitative monitoring CHF symptoms and effective adjusting treatment can prevent re-hospitalization and improve the patient's perception of the disease.
Remote Monitoring in Managing Heart Failure
Resmetrix is the only Quantitative Symptoms Monitoring System for breathing  and Pulmonary Functions worsening in CHF.

Know More – Act Sooner 


Resmetrix sensor is the ONLY wearable that can detect changes in tidal volume, breathing patterns and breathing performance in the healthy and in a medical condition that breathing is affected (CHF, COPD, Asthma) and alert to the patient smartphone, and the medical team, when early signs of respiratory deterioration occur.

(Heart Failure, COPD, Asthma) and alert to the patient smartphone, and the medical team, when early signs of respiratory deterioration occur.

 Resmetrix unique wearable sensor (based on novel proprietary sensor built into a chest strap or a patch over the chest), wirelessly connected to a smartphone app, monitors at-risk patients in real-time, 24/7, anywhere, in any setting. Resmetrix system is the only system that detects small changes in a patient’s breathing pattern, tidal volume and other vital signs (Heart Rate, Temperature)  captures high quality, objective data over time to provide a comprehensive view of patient health and will provide immediate, early warning signs of deterioration in lung function (based on each patient respiratory pattern).

Our tele-monitoring system can monitor Corona patients at home, at quarantine environment or at the Hospital, send alarm to the medical teams when patients are starting to deteriorate, so they can provide treatment early, hence avoiding lung failure and death.  


Clinical Validation

Clinical study at Rambam Medical Center:

  • Resmetrix clinical results show high correlation between respiratory signals from Resmetrix’ strap and a spirometer/flow meter tidal volume signals.
  • In asthmatic patients, the system detected successfully changes in respiratory patterns during mild attack and response to treatment.
  • Studies in exercise, the system demonstrate the ability to continuously and accurately monitor the respiratory signals in various levels of exercise.


About Us

Resmetrix has developed unique portable respiratory monitoring system: A wearable wireless chest strap that monitors, records and analyses continuously and accurately breathing patterns and alerts for early signs of deterioration in a patient’s clinical condition. The system provides a platform of respiratory disease management. 
Resmetrix is a portfolio company of MindUP incubator, a partnership of Medtronic, IBM, Pitango and Rambam Medical Center in Israel. 

Resmetrix won third place in RESI Innovation challenge (Boston, US, Sep. 2019):

The Times of Israel:


Resmetrix started crowdfunding with Together angels club platform:

Resmetrix publication December 2019: